Journal article icon

Journal article

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study

Abstract:

Objectives Remission (REM) or low disease activity (LDA) states were compared in a clinical trial setting of the FUTURE 2 study (NCT01752634) using Disease Activity Index for Psoriatic Arthritis (DAPSA) and Minimal Disease Activity (MDA) composite indices in secukinumab treated PsA patients.

Methods The proportion of patients reaching DAPSA-REM (cut-off ≤4) or REM+LDA (≤14), and very low disease activity (VLDA; achieving 7/7 criteria) or MDA (≥5/7)...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Division:
MSD
Department:
NDORMS
Subgroup:
Botnar Research Centre
Role:
Author
ORCID:
0000-0002-4756-663X
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Seminars in Arthritis and Rheumatism Journal website
Volume:
50
Issue:
4
Pages:
709-718
Publication date:
2020-05-15
Acceptance date:
2020-03-16
DOI:
EISSN:
1532-866X
ISSN:
0049-0172
Pubs id:
1094599
Local pid:
pubs:1094599

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP